AltPep
Seattle, United States· Est.
Develops therapeutics targeting toxic soluble oligomers for neurodegenerative diseases like Alzheimer's and Parkinson's.
Private Company
Total funding raised: $26.6M
About
Develops therapeutics targeting toxic soluble oligomers for neurodegenerative diseases like Alzheimer's and Parkinson's.
RNA & Gene Therapy
Funding History
2Total raised:$26.6M
Series A$23.1M
Seed$3.5M